All stories tagged :

People

ECD Automotive Design Announces 1-for-40 Reverse Stock Split

admin
People

ODDITY to Announce Second Quarter 2025 Financial Results on August 4,...

admin
People

The Honest Company to Report Second Quarter Financial Results on August...

admin
People

Hydrasphere Plus Launches Comprehensive Skincare System Targeting Texture, Muscle Tone, and...

admin
People

Fnac Darty: Revenue up 2.1% in Q2 2025 and +0.7% in...

admin
People

Subscription E-Commerce Industry Report 2025-2030 Featuring Analysis of 34 Companies

admin
People

OLAPLEX Expands Board of Directors with Strategic Appointments

admin
People

Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic...

admin
People

India’s Personal Grooming Market to Experience 19.72% CAGR Through 2025-2030: Unveiling...

admin
People

Marine Lighting Market Size to Surpass USD 542.73 Million by 2032...

admin
People

[Latest] Global Plant Tissue Culture Market Size/Share Worth USD 1,205.94 Million...

admin

Featured

Pr Newswire

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

admin
Pr Newswire

Virtual IT Group and The Instillery Go to Town on Zero...

admin
Pr Newswire

HKUST Deepens Sweden Ties Positioning Hong Kong as a Strategic Nexus...

admin
Pr Newswire

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for...

admin
admin

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

7 new NEFECON® real-world evidence abstracts will be presented at the 18th International lgA Nephropathy Symposium (IIgANN 2025). The newly released results, based on clinical practices at several leading hospitals in China, offer a comprehensive overview of the efficacy and safety of NEFECON® in the treatment of IgA...